JPRN-jRCTs031190163已完成未知
Moisturizing effect and safety study of allantoin combination spray (quasi drug) for the dry skin of the atopic dermatitis patient of the remission maintenance period and safe examination.
Higuchi Ayako0 个研究点目标入组 30 人开始时间: 2019年12月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
The drug under study was confirmed to have improved skin moisturizing ability in patients with atopic dermatitis from skin findings, skin device measurement and skin component analysis. In addition, sufficient safety was confirmed.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 50age old（—）
- 性别
- All
入选标准
- •1) The atopic dermatitis patients that remission maintenance is possible just to use a moisturizer for a whole body (Include the patients who use the external preparation for anti-inflammatory for a part of the whole body).
- •2) The patients who continues remission maintenance more than four weeks.
- •3) The patients who have a skin drying part.
- •4) The patients aged 20-49 at consent.
- •5) The patients with written consent about this study entry.
排除标准
- •1) Subjects who have the skin disease except the target disease and other diseases that it is thought that the diseases affect this study.
- •2) Subjects who have the injury that it is thought that the diseases affect this study or exanthem is the one in the observation part.
- •3) Subjects who is thought that the drug (systemic steroid, immunosuppressive drug, dupilumab preparation, et al) to influence on this study is necessary within four weeks before study start or in future.
- •4) Subjects who have the contact dermatitis with the past for cosmetics.
- •5) Pregnant or possibly pregnant women, breastfeeding women, or women who wish to become pregnant during study participation.
- •6) Subjects who participated in other clinical studies in the past 3 months.
- •7) In addition, subjects that it is judged by responsible doctor that participation in final examination is inappropriate.
研究者
相似试验
已完成
3 期
Emollients in the Management of Atopic DermatitisAtopic DermatitisNCT01779258Pierre Fabre Medicament347
已完成
不适用
Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic DermatitisAllergy PollenAtopic DermatitisNCT03315611Fraunhofer-Institute of Toxicology and Experimental Medicine23
尚未招募
3 期
Clinical studies on moisturizing effect skin and brightening of sleeping mask contained with beta â€glucan extractHealthy males and femalesbetaglucanbrightening effecthealthy skinclinical trialTCTR20190817002Thailand Institute of Scientific and Technology Research (TISTIR)40
已完成
不适用
Metronidazole SC Penetrance With MoisturizersRosacea, ErythematotelangiectaticNCT06434519Duke University21
已完成
1 期
Clinical test for development of novel skin care method by augmentation of Staphylococcus epidermidis, an autologous skin microbiotaImprovement of skin moisture retentionJPRN-UMIN000012829agasaki International University20